{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:39:27Z","timestamp":1781455167128,"version":"3.54.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10792-021-01996-7","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T11:10:03Z","timestamp":1628680203000},"page":"323-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-5371","authenticated-orcid":false,"given":"Sagnik","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Babu","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu P.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Baliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshavardhan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"issue":"10223","key":"1996_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497\u2013506","journal-title":"China Lancet"},{"issue":"19","key":"1996_CR2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.0000000000009455","volume":"94","author":"A Nath","year":"2020","unstructured":"Nath A (2020) Neurologic complications of coronavirus infections. Neurology 94(19):809\u2013810","journal-title":"Neurology"},{"issue":"6","key":"1996_CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683\u2013690","journal-title":"China JAMA Neurol"},{"issue":"7","key":"1996_CR4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 11(7):995\u2013998","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"1996_CR5","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264\u201375","journal-title":"J Virol"},{"key":"1996_CR6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00277-020-04138-8","volume":"99","author":"M Marchetti","year":"2020","unstructured":"Marchetti M (2020) COVID-19-driven endothelial damage: Complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann Hematol 99:1701\u20131707","journal-title":"Ann Hematol"},{"issue":"10","key":"1996_CR7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1-34","journal-title":"J Clin Epidemiol"},{"key":"1996_CR8","doi-asserted-by":"crossref","unstructured":"Pereira LA, Soares LCM, Nascimento PA, Cirillo LRN, Sakuma HT, Veiga GLD, et al. (2020) Retinal findings in hospitalised patients with severe COVID-19. Br J Ophthalmol, 16:bjophthalmol-2020\u2013317576","DOI":"10.1136\/bjophthalmol-2020-317576"},{"key":"1996_CR9","doi-asserted-by":"crossref","first-page":"100550","DOI":"10.1016\/j.eclinm.2020.100550","volume":"27","author":"A Invernizzi","year":"2020","unstructured":"Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V et al (2020) Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine 27:100550","journal-title":"EClinicalMedicine"},{"key":"1996_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100958","author":"R D'Aloisio","year":"2020","unstructured":"D\u2019Aloisio R, Nasillo V, Gironi M, Mastropasqua R (2020) Bilateral macular hemorrhage in a patient with COVID-19. Am J Ophthalmol Case Rep. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100958","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"10237","key":"1996_CR11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","volume":"395","author":"PM Marinho","year":"2020","unstructured":"Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr (2020) Retinal findings in patients with COVID-19. Lancet 395(10237):1610","journal-title":"Lancet"},{"issue":"1","key":"1996_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13156","volume":"289","author":"MF Landecho","year":"2020","unstructured":"Landecho MF, Yuste JR, G\u00e1ndara E, Sunsundegui P, Quiroga J, Alcaide AB et al (2020) COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med 289(1):116\u201320","journal-title":"J Intern Med"},{"issue":"8","key":"1996_CR13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1080\/09273948.2020.1807023","volume":"28","author":"A Invernizzi","year":"2020","unstructured":"Invernizzi A, Pellegrini M, Messenio D, Cereda M, Olivieri P, Brambilla AM et al (2020) Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm 28(8):1290\u20131292","journal-title":"Ocul Immunol Inflamm"},{"key":"1996_CR14","first-page":"112067212094759","volume":"30","author":"A Insausti-Garc\u00eda","year":"2020","unstructured":"Insausti-Garc\u00eda A, Reche-Sainz JA, Ruiz-Arranz C, L\u00f3pez V\u00e1zquez \u00c1, Ferro-Osuna M (2020) Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol 30:1120672120947591","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"1996_CR15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/ijo.IJO_2380_20","volume":"68","author":"JU Sheth","year":"2020","unstructured":"Sheth JU, Narayanan R, Goyal J, Goyal V (2020) Retinal vein occlusion in COVID-19: a novel entity. Indian J Ophthalmol 68(10):2291\u20132293","journal-title":"Indian J Ophthalmol"},{"key":"1996_CR16","first-page":"e927691","volume":"21","author":"WH Gaba","year":"2020","unstructured":"Gaba WH, Ahmed D, Al Nuaimi RK, Dhanhani AA, Eatamadi H (2020) Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) Pneumonia. Am J Case Rep 21:e927691","journal-title":"Am J Case Rep"},{"issue":"11","key":"1996_CR17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.4103\/ijo.IJO_2575_20","volume":"68","author":"JA Walinjkar","year":"2020","unstructured":"Walinjkar JA, Makhija SC, Sharma HR, Morekar SR, Natarajan S (2020) Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 68(11):2572\u20132574","journal-title":"Indian J Ophthalmol"},{"key":"1996_CR18","doi-asserted-by":"crossref","first-page":"e00867","DOI":"10.1016\/j.idcr.2020.e00867","volume":"21","author":"S Acharya","year":"2020","unstructured":"Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P (2020) Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases 21:e00867","journal-title":"IDCases"},{"issue":"8","key":"1996_CR19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/09273948.2020.1825751","volume":"28","author":"P Gascon","year":"2020","unstructured":"Gascon P, Briantais A, Bertrand E, Ramtohul P, Comet A, Beylerian M et al (2020) Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm 28(8):1293\u20131297","journal-title":"Ocul Immunol Inflamm"},{"key":"1996_CR20","volume-title":"Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection","author":"J Virgo","year":"2020","unstructured":"Virgo J, Mohamed M (2020) Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Published online July, Eye"},{"issue":"8","key":"1996_CR21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1080\/09273948.2020.1821898","volume":"28","author":"LA Zago Filho","year":"2020","unstructured":"Zago Filho LA, Lima LH, Melo GB, Zett C, Farah ME (2020) Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocul Immunol Inflamm 28(8):1298\u20131300","journal-title":"Ocul Immunol Inflamm"},{"key":"1996_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16801","author":"L Quintana-Castanedo","year":"2020","unstructured":"Quintana-Castanedo L, Feito-Rodr\u00edguez M, Fern\u00e1ndez-Alcalde C, Granados-Fern\u00e1ndez M, Montero-Vega D, Mayor-Ibarguren A et al (2020) Concurrent chilblains and retinal vasculitis in a child with COVID-19. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.16801","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1996_CR23","doi-asserted-by":"crossref","first-page":"17419","DOI":"10.1038\/s41598-020-74446-6","volume":"10","author":"MP Pirraglia","year":"2020","unstructured":"Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d\u2019Ettorre G, Mastroianni CM et al (2020) Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep 10(1):17419","journal-title":"Sci Rep"},{"key":"1996_CR24","doi-asserted-by":"crossref","first-page":"e2020013","DOI":"10.4178\/epih.e2020013","volume":"42","author":"Y Jee","year":"2020","unstructured":"Jee Y (2020) WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health 42:e2020013","journal-title":"Epidemiol Health"},{"issue":"16","key":"1996_CR25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2020.4031","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Pesenti A, Cecconi M (2020) Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 323(16):1545\u20131546","journal-title":"JAMA"},{"issue":"2","key":"1996_CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S et al (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38(2):337\u2013342","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1996_CR27","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","volume":"38","author":"B Long","year":"2020","unstructured":"Long B, Brady WJ, Koyfman A, Gottlieb M (2020) Cardiovascular complications in COVID-19. Am J Emerg Med 38(7):1504\u20131507","journal-title":"Am J Emerg Med"},{"issue":"5","key":"1996_CR28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cns.13372","volume":"26","author":"AM Baig","year":"2020","unstructured":"Baig AM (2020) Neurological manifestations in COVID-19 caused by SARS-CoV-2. Ther CNS Neurosci 26(5):499\u2013501","journal-title":"Ther CNS Neurosci"},{"issue":"5","key":"1996_CR29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","volume":"138","author":"P Wu","year":"2020","unstructured":"Wu P, Duan F, Luo C (2020) Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province. China JAMA Ophthalmol 138(5):575\u2013578","journal-title":"China JAMA Ophthalmol"},{"key":"1996_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2020.03.003","author":"M Cheema","year":"2020","unstructured":"Cheema M, Aghazadeh H, Nazarali S et al (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. https:\/\/doi.org\/10.1016\/j.jcjo.2020.03.003","journal-title":"Can J Ophthalmol"},{"key":"1996_CR31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jfo.2020.04.002","volume":"43","author":"A Daruich","year":"2020","unstructured":"Daruich A, Martin D, Bremond-Gignac D (2020) Ocular manifestation as first sign of coronavirus disease 2019 (COVID-19): interest of telemedicine during the pandemic context. J Fr Ophtalmol 43:389\u2013391","journal-title":"J Fr Ophtalmol"},{"issue":"17","key":"1996_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00404-18","volume":"92","author":"M Dub\u00e9","year":"2018","unstructured":"Dub\u00e9 M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ (2018) (2018) Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol 92(17):1\u201321","journal-title":"J Virol"},{"key":"1996_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep00736","volume":"2","author":"VJ Munster","year":"2012","unstructured":"Munster VJ, Prescott JB, Bushmaker T, Long D, Rosenke R, Thomas T et al (2012) Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep 2:1\u20138","journal-title":"Sci Rep"},{"key":"1996_CR34","first-page":"995","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM et al (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms, ACS Chem. Neurosci 11:995\u2013998","journal-title":"Neurosci"},{"key":"1996_CR35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/09273948.2020.1770301","volume":"28","author":"M Casagrande","year":"2020","unstructured":"Casagrande M, Fitzek A, Pu\u00a8schel K et al (2020) Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm 28:721\u2013725","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"1996_CR36","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.06-1024","volume":"48","author":"P Senanayake","year":"2007","unstructured":"Senanayake P, Drazba J, Shadrach K et al (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48(7):3301\u20133311","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1996_CR37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418","journal-title":"Lancet"},{"key":"1996_CR38","first-page":"M20","volume":"6","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake JP, L\u00fctgehetmann M, Steurer S, Edler C, Heinemann A et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med 6:M20-2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"1996_CR39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.120.15353","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F (2020) COVID-19: ACE2 centric infective disease? Hypertension 76(2):294\u2013299","journal-title":"Hypertension"},{"key":"1996_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.thromres.2013.05.026","volume":"132","author":"Y Yamaguchi","year":"2013","unstructured":"Yamaguchi Y, Moriki T, Igari A, Matsubara Y, Ohnishi T, Hosokawa K, Murata M (2013) Studies of a microchip flowchamber system to characterize whole blood thrombogenicity in healthy individuals. Thromb Res 132:263\u2013270","journal-title":"Thromb Res"},{"key":"1996_CR41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nri3898","volume":"15","author":"O Leavy","year":"2015","unstructured":"Leavy O (2015) NETting a one-two punch. Nat Rev Immunol 15:526\u2013527","journal-title":"Nat Rev Immunol"},{"key":"1996_CR42","volume-title":"Iba T (2020) The influence of hyperglycaemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes","author":"T Hirota","year":"1994","unstructured":"Hirota T, Levy JH (1994) Iba T (2020) The influence of hyperglycaemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes. Microcirculation (New York, NY"},{"issue":"20","key":"1996_CR43","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60","journal-title":"N Engl J Med"},{"key":"1996_CR44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9\u201314","journal-title":"Thromb Res"},{"issue":"23","key":"1996_CR45","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E et al (2020) Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 75(23):2950\u20132973","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1996_CR46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120\u2013128","journal-title":"N Engl J Med"},{"key":"1996_CR47","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID- 19. Lancet 395:1417\u20131418","journal-title":"Lancet"},{"issue":"6","key":"1996_CR48","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 7(6):e438\u2013e440440","journal-title":"Lancet Haematol"},{"issue":"20","key":"1996_CR49","first-page":"30120","volume":"S0049\u20133848","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res S0049\u20133848(20):30120\u20131","journal-title":"Thromb Res"},{"key":"1996_CR50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148\u2013150","journal-title":"Thromb Res"},{"key":"1996_CR51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3174\/ajnr.A6644","volume":"41","author":"DD Cavalcanti","year":"2020","unstructured":"Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K et al (2020) Cerebral venous thrombosis associated with COVID-19. Am J Neuroradiol 41:1370\u20131376","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"1996_CR52","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/jth.14842","volume":"18","author":"A Porfidia","year":"2020","unstructured":"Porfidia A, Pola R (2020) Venous thromboembolism in COVID-19 patients. J Thromb Haemost 18(6):1516\u20131517","journal-title":"J Thromb Haemost"},{"issue":"10","key":"1996_CR53","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/jmv.25884","volume":"92","author":"J Zhu","year":"2020","unstructured":"Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C (2020) Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol 92(10):1902\u201314","journal-title":"J Med Virol"},{"issue":"5","key":"1996_CR54","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023\u20131026","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1996_CR55","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/jcm9061651","volume":"9","author":"B Marchandot","year":"2020","unstructured":"Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L et al (2020) COVID-19 Related coagulopathy: a distinct entity? J Clin Med 9(6):1651","journal-title":"J Clin Med"},{"issue":"1","key":"1996_CR56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-020-02146-z","volume":"50","author":"M Artifoni","year":"2020","unstructured":"Artifoni M, Danic G, Gautier G, Gicquel P, Boutoille D, Raffi F et al (2020) Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis 50(1):211\u2013216","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"1996_CR57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan. China. JAMA Neurol 77(6):683\u2013690","journal-title":"China. JAMA Neurol"},{"issue":"7","key":"1996_CR58","doi-asserted-by":"crossref","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","volume":"9","author":"J Guo","year":"2020","unstructured":"Guo J, Huang Z, Lin L, Lv J (2020) Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc 9(7):e016219","journal-title":"J Am Heart Assoc"},{"key":"1996_CR59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91\u201395","journal-title":"Int J Infect Dis"},{"issue":"10229","key":"1996_CR60","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062","journal-title":"Lancet"},{"key":"1996_CR61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","volume":"87","author":"A Avula","year":"2020","unstructured":"Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S et al (2020) COVID-19 presenting as stroke. Brain Behav Immun 87:115\u2013119","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1996_CR62","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738\u20131742","journal-title":"J Thromb Haemost"},{"key":"1996_CR63","doi-asserted-by":"publisher","unstructured":"Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 4;135(23):2033\u20132040. https:\/\/doi.org\/10.1182\/blood.2020006000","DOI":"10.1182\/blood.2020006000"},{"issue":"5","key":"1996_CR64","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","volume":"132","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH (2020) Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology 132(5):1238\u20131245","journal-title":"Anesthesiology"},{"key":"1996_CR65","doi-asserted-by":"publisher","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089\u20131098. https:\/\/doi.org\/10.1007\/s00134-020-06062-x","DOI":"10.1007\/s00134-020-06062-x"},{"issue":"8","key":"1996_CR66","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P et al (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7(8):e575\u2013e582","journal-title":"Lancet Haematol"},{"issue":"3","key":"1996_CR67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/svn-2020-000431","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5(3):279\u2013284","journal-title":"Stroke Vasc Neurol"},{"issue":"10229","key":"1996_CR68","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054","journal-title":"Lancet"},{"issue":"7","key":"1996_CR69","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 18(7):1747\u20131751","journal-title":"J Thromb Haemost"},{"key":"1996_CR70","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1148\/radiol.2020201629","volume":"297","author":"M Oudkerk","year":"2020","unstructured":"Oudkerk M, B\u00fcller HR, Kuijpers D, van Es N, Oudkerk SF, McLoud T et al (2020) Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the national institute for public health of the Netherlands. Radiology 297:E216\u2013E222","journal-title":"Radiology"},{"key":"1996_CR71","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38","journal-title":"N Engl J Med"},{"key":"1996_CR72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle B (2020) Severe COVID-19 infection associated with endothelial activation. Thromb Res 190:62","journal-title":"Thromb Res"},{"key":"1996_CR73","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1093\/cid\/ciq125","volume":"52","author":"PE Bunce","year":"2016","unstructured":"Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD (2016) Pandemic H1N1 influenza infection and vascular thrombosis. Clin Infect Dis 52:e14\u2013e17","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1996_CR74","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jvscit.2020.06.001","volume":"6","author":"K Garg","year":"2020","unstructured":"Garg K, Barfield ME, Pezold ML, Sadek M, Cayne NS, Lugo J et al (2020) Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels. J Vasc Surg Cases Innov Tech 6(3):348\u2013351","journal-title":"J Vasc Surg Cases Innov Tech"},{"issue":"2","key":"1996_CR75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.120.047407","volume":"142","author":"B Ren","year":"2020","unstructured":"Ren B, Yan F, Deng Z, Zhang S, Xiao L, Wu M, Cai L (2020) Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan. Circulation 142(2):181\u2013183","journal-title":"Circulation"},{"key":"1996_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.01","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.01","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1996_CR77","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood.2020008086","volume":"136","author":"LN Roberts","year":"2020","unstructured":"Roberts LN, Whyte MB, Georgiou L, Giron G, Czuprynska J, Rea C et al (2020) Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood 136(11):1347\u20131350","journal-title":"Blood"},{"issue":"6","key":"1996_CR78","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","volume":"375","author":"AT Cohen","year":"2016","unstructured":"Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Investigators APEX et al (2016) Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. N Engl J Med 375(6):534\u201344","journal-title":"N Engl J Med"},{"issue":"5","key":"1996_CR79","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood-2016-10-747931","volume":"129","author":"DL Tao","year":"2017","unstructured":"Tao DL, Bien JY, DeLoughery TG, Shatzel JJ (2017) Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis. Blood 129(5):653\u2013655","journal-title":"Blood"},{"issue":"23","key":"1996_CR80","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E et al (2020) J Am Coll Cardiol 75(23):2950\u20132973","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1996_CR81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","volume":"50","author":"GD Barnes","year":"2020","unstructured":"Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A et al (2020) Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis 50(1):72\u201381","journal-title":"J Thromb Thrombolysis"},{"key":"1996_CR82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","volume":"50","author":"RC Becker","year":"2020","unstructured":"Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 50:54\u201367","journal-title":"J Thromb Thrombolysis"},{"issue":"10239","key":"1996_CR83","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D\u2019Antiga L (2020) An outbreak of severe Kawasaki- like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395(10239):1771\u20131778","journal-title":"Lancet"},{"key":"1996_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16713","author":"D de Perosanz-Lobo","year":"2020","unstructured":"de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C et al (2020) Urticarial vasculitis in COVID-19 infection: a vasculopathyrelated symptom? J Eur Acad Dermatol Venereol JEADV. https:\/\/doi.org\/10.1111\/jdv.16713","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"1996_CR85","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1212\/NXI.0000000000000813","volume":"7","author":"AA Pinto","year":"2020","unstructured":"Pinto AA, Carroll LS, Nar V, Varatharaj A, Galea I (2020) CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19. Neurol Neuroimmunol Neuroinflamm 7:e813","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1996_CR86","doi-asserted-by":"crossref","first-page":"108487","DOI":"10.1016\/j.clim.2020.108487","volume":"29","author":"L Roncati","year":"2020","unstructured":"Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B et al (2020) Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol 29:108487","journal-title":"Clin Immunol"},{"key":"1996_CR87","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844\u2013847","journal-title":"J Thromb Haemost"},{"key":"1996_CR88","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","volume":"28","author":"I Seah","year":"2020","unstructured":"Seah I, Agrawal R (2020) Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals. Ocul immunol Inflamm 28:391\u2013395","journal-title":"Ocul immunol Inflamm"},{"issue":"6","key":"1996_CR89","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.151.6.3381","volume":"151","author":"JJ Hooks","year":"1993","unstructured":"Hooks JJ, Percopo C, Wang Y, Detrick B (1993) Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J Immunol 151(6):3381\u20139","journal-title":"J Immunol"},{"issue":"4","key":"1996_CR90","first-page":"417","volume":"159","author":"MJ Doherty","year":"1971","unstructured":"Doherty MJ (1971) Ocular manifestations of feline infectious peritonitis. J Am Vet Med Assoc 159(4):417\u201324","journal-title":"J Am Vet Med Assoc"},{"key":"1996_CR91","doi-asserted-by":"crossref","first-page":"105282","DOI":"10.1016\/j.dib.2020.105282","volume":"29","author":"MU Akram","year":"2020","unstructured":"Akram MU, Akbar S, Hassan T, Khawaja SG, Yasin U, Basit I (2020) Data on fundus images for vessels segmentation, detection of hypertensive retinopathy, diabetic retinopathy and papilledema. Data Brief 29:105282","journal-title":"Data Brief"},{"key":"1996_CR92","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00006324-200011000-00010","volume":"77","author":"C Jaworski","year":"2000","unstructured":"Jaworski C (2000) Morphology of the HIV versus the diabetic cotton wool spot. Optom Vis Sci 77:600\u2013604","journal-title":"Optom Vis Sci"},{"key":"1996_CR93","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46:586\u2013590","journal-title":"Intensive Care Med"},{"key":"1996_CR94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","volume":"20","author":"A Verma","year":"2012","unstructured":"Verma A, Shan Z, Lei B et al (2012) ACE2 and Ang-(1\u20137) confer protection against development of diabetic retinopathy. Mol Ther 20:28\u201336","journal-title":"Mol Ther"},{"key":"1996_CR95","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/stem.2848","volume":"36","author":"Y Duan","year":"2018","unstructured":"Duan Y, Beli E, Li Calzi S et al (2018) Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction. Stem Cells 36:1430\u20131440","journal-title":"Stem Cells"},{"key":"1996_CR96","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s10792-020-01330-7","volume":"40","author":"A Mahdjoubi","year":"2020","unstructured":"Mahdjoubi A, Bousnina Y, Barrande G, Bensmaine F, Chahed S, Ghezzaz A (2020) Features of cotton wool spots in diabetic retinopathy: a spectral-domain optical coherence tomography angiography study. Int Ophthalmol 40:1625\u20131640","journal-title":"Int Ophthalmol"},{"issue":"1\u20132","key":"1996_CR97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2005.05.018","volume":"166","author":"LC Hooper","year":"2005","unstructured":"Hooper LC, Chin MS, Detrick B, Hooks JJ (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166(1\u20132):65\u201374","journal-title":"J Neuroimmunol"},{"issue":"10229","key":"1996_CR98","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034","journal-title":"Lancet"},{"issue":"1","key":"1996_CR99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11427-014-4790-3","volume":"58","author":"J Xu","year":"2015","unstructured":"Xu J, Tan D, Fu Y, Walline J, Yu X (2015) Do corticosteroids have a role in treating Ebola virus disease? Sci China Life Sci 58(1):111\u2013113","journal-title":"Sci China Life Sci"},{"issue":"5","key":"1996_CR100","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10792-020-01389-2","volume":"40","author":"P Neri","year":"2020","unstructured":"Neri P, Pichi F (2020) COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol 40(5):1057\u20131060. https:\/\/doi.org\/10.1007\/s10792-020-01389-2","journal-title":"Int Ophthalmol"},{"key":"1996_CR101","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41423-021-00685-w","volume":"18","author":"Y Liang","year":"2021","unstructured":"Liang Y, Ge Y, Sun J (2021) IL-33 in COVID-19: a friend or foe? Cell Mol Immunol 18:1602\u20131604","journal-title":"Cell Mol Immunol"},{"key":"1996_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-020-0098-4","author":"GS Schulert","year":"2020","unstructured":"Schulert GS, Cron RQ (2020) The genetics of macrophage activation syndrome. Genes Immun. https:\/\/doi.org\/10.1038\/s41435-020-0098-4","journal-title":"Genes Immun"},{"issue":"6","key":"1996_CR103","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20(6):363\u2013374","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1996_CR104","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10792-020-01495-1","volume":"40","author":"P Neri","year":"2020","unstructured":"Neri P, Lamperti M, Pichi F (2020) SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models. Int Ophthalmol 40(8):1879\u20131883. https:\/\/doi.org\/10.1007\/s10792-020-01495-1","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01996-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01996-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01996-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T03:51:41Z","timestamp":1673063501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01996-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01996-7","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}